Clinical Trial Update: Effect of PUR003 on Asthma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating PUR003 for asthma has been completed; the update does not disclose trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PUR003

Snippet

Sponsor: Pulmatrix Inc. | Conditions: Asthma, Lung Diseases | Phase 1 | Status: COMPLETED